Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Zamvil

Showing results (51-60 of 253) with videos related to

Pageof 26
Sort By:
Journal of the National Cancer Institute|March 1, 1980
Response to the RIF-1 tumor in vitro and in C3H/Km mice to X-radiation (cell survival, regrowth delay, and tumor control), chemotherapeutic agents, and activated macrophagesJ M Brown, P R Twentyman, S S Zamvil
Current Opinion in Immunology|October 11, 2011
B cells in multiple sclerosis: connecting the dotsH-Christian von Büdingen, Amit Bar-Or, Scott S Zamvil
Trends in Immunology|March 15, 2006
A neuropeptide in immune-mediated inflammation, Y?Thomas Prod'homme, Martin S Weber, Lawrence Steinman, et al.
Nature Clinical Practice. Neurology|August 26, 2006
Drug Insight: using statins to treat neuroinflammatory diseaseMartin S Weber, Thomas Prod'homme, Lawrence Steinman, et al.
The Lancet. Neurology|May 26, 2004
Are statins a treatment option for multiple sclerosis?Oliver Neuhaus, Olaf Stüve, Scott S Zamvil, et al.
Journal of Neuroimmunology|August 1, 1983
Prevention of experimental allergic encephalitis with in vivo administration of anti I-A antibody. Decreased accumulation of radiolabelled lymph node cells in the central nervous systemL Steinman, D Solomon, M Lim, et al.
CNS Drugs|September 28, 2005
Evaluation of HMG-CoA reductase inhibitors for multiple sclerosis: opportunities and obstaclesOliver Neuhaus, Olaf Stüve, Scott S Zamvil, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 15, 2019
N2 year in review and message from the editor to our reviewersJosep Dalmau, Dennis L Kolson, Friedemann Paul, et al.
Journal of Neuroimmunology|July 17, 1999
Highlights from the Fifth International Congress of the International Society of NeuroimmunologyM S Freedman, R Ransohoff, P J Talbot, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 13, 2020
Should interferons take front stage as an essential MS disease-modifying therapy in the era of coronavirus disease 2019?Cole Maguire, Teresa Frohman, Scott S Zamvil, et al.
Pageof 26

Showing results (51-60 of 253) with videos related to

Sort By:
Pageof 26
Journal of the National Cancer Institute|March 1, 1980
Response to the RIF-1 tumor in vitro and in C3H/Km mice to X-radiation (cell survival, regrowth delay, and tumor control), chemotherapeutic agents, and activated macrophagesJ M Brown, P R Twentyman, S S Zamvil
Current Opinion in Immunology|October 11, 2011
B cells in multiple sclerosis: connecting the dotsH-Christian von Büdingen, Amit Bar-Or, Scott S Zamvil
Trends in Immunology|March 15, 2006
A neuropeptide in immune-mediated inflammation, Y?Thomas Prod'homme, Martin S Weber, Lawrence Steinman, et al.
Nature Clinical Practice. Neurology|August 26, 2006
Drug Insight: using statins to treat neuroinflammatory diseaseMartin S Weber, Thomas Prod'homme, Lawrence Steinman, et al.
The Lancet. Neurology|May 26, 2004
Are statins a treatment option for multiple sclerosis?Oliver Neuhaus, Olaf Stüve, Scott S Zamvil, et al.
Journal of Neuroimmunology|August 1, 1983
Prevention of experimental allergic encephalitis with in vivo administration of anti I-A antibody. Decreased accumulation of radiolabelled lymph node cells in the central nervous systemL Steinman, D Solomon, M Lim, et al.
CNS Drugs|September 28, 2005
Evaluation of HMG-CoA reductase inhibitors for multiple sclerosis: opportunities and obstaclesOliver Neuhaus, Olaf Stüve, Scott S Zamvil, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 15, 2019
N2 year in review and message from the editor to our reviewersJosep Dalmau, Dennis L Kolson, Friedemann Paul, et al.
Journal of Neuroimmunology|July 17, 1999
Highlights from the Fifth International Congress of the International Society of NeuroimmunologyM S Freedman, R Ransohoff, P J Talbot, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|June 13, 2020
Should interferons take front stage as an essential MS disease-modifying therapy in the era of coronavirus disease 2019?Cole Maguire, Teresa Frohman, Scott S Zamvil, et al.
Pageof 26